Evidence map›Paper›PMID 28385446›Full record

ReviewThe Journal of prosthetic dentistry2017

Dental and orofacial mesenchymal stem cells in craniofacial regeneration: The prosthodontist's point of view.

Sahar Ansari, Jackson T Seagroves, Chider Chen, Kumar Shah, Tara Aghaloo, Benjamin M Wu, Sompop Bencharit, Alireza Moshaverinia

Abstract readReview
In one paragraph

Review in The Journal of prosthetic dentistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Human dental follicle mesenchymal stem cells alleviate T cell response in inflamed tissue of Crohn's patients.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2020
    Trial
  2. The Therapeutic Scope of Orofacial Mesenchymal Stem Cells.Bioengineering (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Advances on Hydrogels for Oral Science Research.Gels (Basel, Switzerland) · 2022
    Review
  9. Therapeutic application of hydrogels for bone-related diseases.Frontiers in bioengineering and biotechnology · 2022
    Review
  10. Review
  11. Review
  12. Hydrogels and Their Role in Bone Tissue Engineering: An Overview.Journal of pharmacy & bioallied sciences · 2021
    Review
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sahar AnsariLecturer, Division of Oral Biology, School of Dentistry, University of California, Los Angeles, Calif.
Jackson T SeagrovesStudent, Department of Dental Research, School of Dentistry, University of North Carolina, Chapel Hill, NC.
Chider ChenPostdoctoral research fellow, Department of Anatomy and Cell Biology, School of Dental Medicine University of Pennsylvania, Philadelphia, Pa.
Kumar ShahAssociate Professor and Program Director, Graduate Program in Prosthodontics, Division of Advanced Prosthodontics, School of Dentistry, University of California, Los Angeles, Calif.
Tara AghalooProfessor, Division of Advanced Prosthodontics and Director, Weintraub Center for Reconstructive Biotechnology, School of Dentistry, University of California, Los Angeles, Calif.
Benjamin M WuProfessor and Chair, Division of Advanced Prosthodontics and Director, Weintraub Center for Reconstructive Biotechnology, School of Dentistry, University of California, Los Angeles, Calif.
Sompop BencharitAssociate Professor and Director, Digital Dentistry Technologies, Department of General Practice and Department of Oral & Maxillofacial Surgery, School of Dentistry, and Department of Biomedical Engineering, School of Engineering, Virginia Commonwealth University, Richmond, VA.
Alireza MoshaveriniaAssistant Professor, Weintraub Center for Reconstructive Biotechnology, Division of Advanced Prosthodontics, School of Dentistry, University of California, Los Angeles, Calif. Electronic address: amoshaverinia@ucla.edu.

Funding

FAS Controls Exosome-Mediated miRNA Transfer in MSC-Based TherapyR00DE025915 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI CHEN, CHI-DER · 2019 to 2021
$732k
A NOVEL STEM CELL BASED DELIVERY SYSTEM TO IMPROVE BONE TISSUE REGENERATIONK08DE023825 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MOSHAVERINIA, ALIREZA · 2014 to 2018
$619k
FAS Controls Exosome-Mediated miRNA Transfer in MSC-Based TherapyK99DE025915 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI CHEN, CHI-DER · 2016 to 2017
$142k
Craniofacial Diseases and Solutions in Man and AnimalsR13DE026694 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MOSHAVERINIA, ALIREZA · 2016 to 2016
$8k
NIDCR NIH HHS K08 DE023825NIDCR NIH HHS K99 DE025915NIDCR NIH HHS R00 DE025915NIDCR NIH HHS R13 DE026694
6 · The paper itself

Abstract

Of the available regenerative treatment options, craniofacial tissue regeneration using mesenchymal stem cells (MSCs) shows promise. The ability of stem cells to produce multiple specialized cell types along with their extensive distribution in many adult tissues have made them an attractive target for applications in tissue engineering. MSCs reside in a wide spectrum of postnatal tissue types and have been successfully isolated from orofacial tissues. These dental- or orofacial-derived MSCs possess self-renewal and multilineage differentiation capacities. The craniofacial system is composed of complex hard and soft tissues derived from sophisticated processes starting with embryonic development. Because of the complexity of the craniofacial tissues, the application of stem cells presents challenges in terms of the size, shape, and form of the engineered structures, the specialized final developed cells, and the modulation of timely blood supply while limiting inflammatory and immunological responses. The cell delivery vehicle has an important role in the in vivo performance of stem cells and could dictate the success of the regenerative therapy. Among the available hydrogel biomaterials for cell encapsulation, alginate-based hydrogels have shown promising results in biomedical applications. Alginate scaffolds encapsulating MSCs can provide a suitable microenvironment for cell viability and differentiation for tissue regeneration applications. This review aims to summarize current applications of dental-derived stem cell therapy and highlight the use of alginate-based hydrogels for applications in craniofacial tissue engineering.

Indexed as

Attitude of Health PersonnelDentistryFaceMesenchymal Stem CellsSkullTissue EngineeringHumansMouthRegeneration

Identifiers

PMID28385446
PMCPMC5623090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.